The Fight Against Antimicrobial Resistance: A Promising Broad Host-Range CRISPR-Cas9 Delivery Tool for AMR Plasmid Removal

FHS
June 21, 2023
7:38 am

Study removes AMR plasmids using a mobile, broad-host-range CRISPR-Cas9 delivery tool.

Fulcrum’s sickle cell hold resolved, and trial will now focus on more severe patients

Fulcrum Therapeutics can resume testing its oral capsule in a Phase Ib study in patients with sickle cell disease, the biotech said Tuesday morning. The

August 23, 2023

Hospital Deaths Investigated; Price Hikes for 500 Drugs; Mushroom Poisonings Rise

Note that some links may require registration or subscription. Police are investigating an Oregon hospital where several patients died after reportedly receiving tap water injections

January 3, 2024

What ever happened to biotech’s big comeback?

This was supposed to be the year of the biotech comeback, when promising new medicines and high-dollar buyouts would reverse a sector-wide slump that dates

September 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.